Showing 101-110 of 792 results for "".
Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Top 5 Skincare Trends on Social Media: What is Truly “Verified?”
https://practicaldermatology.com/issues/june-2024/top-5-skincare-trends-on-social-media-what-is-truly-verified/26556/Top 5 Skincare Trends on Social Media: What is Truly “Verified?”Exploring the Connection Between Gut Health and Hair
https://practicaldermatology.com/issues/supplements/exploring-the-connection-between-gut-health-and-hair/23089/Sponsored by Nutrafol®Exploring the Connection Between Gut Health and Hair
https://practicaldermatology.com/topics/general-topics/exploring-the-connection-between-gut-health-and-hair-1/23110/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-5/23092/Are We Overlooking Skin Cancer in Ethnic Minorities?
https://practicaldermatology.com/issues/supplements/are-we-overlooking-skin-cancer-in-ethnic-minorities/21718/Skin cancers in Hispanic and African American patients may be detected at more advanced stages, leading to poorer prognoses and long-term outcomes compared to non-Hispanic whites.Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.New Products
https://practicaldermatology.com/columns/new-products/new-products-4/23753/Targeting Cellulite: Evolving Approaches
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/targeting-cellulite-evolving-approaches/23796/New treatments mean that dermatologists can improve treatment outcomes for the 90% of women who have cellulite.Advances in the Treatment of Reticular Erythematous Mucinosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/advances-in-the-treatment-of-reticular-erythematous-mucinosis/23491/Considering nicotinamide’s anti-inflammatory properties for inflammatory dermatological conditions to avoid steroid and antibiotic overuse.